Jarvik Responds to Lipitor Ad Controversy
Jarvik says his role in Lipitor ad currently being investigated is educational.
Jan. 16, 2008 — -- Robert Jarvik, the inventor of the artificial heart, is at the center of a congressional investigation into his credentials and his role as pitchman for the top-selling cholesterol-lowering drug Lipitor.
In the commercials, Jarvik says, "Lipitor is one of the most researched medicines. I'm glad I take Lipitor, as a doctor, and a dad."
Despite his famous medical breakthrough, Jarvik ended his training after medical school, instead of completing a medical internship. He can't legally prescribe medicine to anyone and he is not licensed to practice medicine.
"I am a medical scientist not a practical physician," he said on "Good Morning America" today. "I think it's very upfront. I am a doctor. I have long experience with heart disease."
Jarvik, who said he was aware of the drug and used it before he became its pitchman, said he believes the real issue isn't about him or his role in the ads.
His goal is to disseminate the message of preventive medicine in relation to heart disease.
"Our ad campaign with Pfizer is an educational," he said. "Lipitor is the most widely prescribed drug in the country. For every prescription there is a doctor writing it. It's a huge vote of confidence."
Michigan Reps. John Dingell and Bart Stupak, both Democrats, sent a letter to drug company Pfizer last week, questioning Jarvik's credibility.
"Is he entitled to appear here and prescribe or give the impression he can prescribe prescription pharmaceuticals for patients?" Dingell said. "I think the law in every state says, no he's not, because he can't prescribe medicine in any state we can find."
Pfizer released a statement, saying, "Dr. Jarvik is a respected health-care professional and heart expert. The advertising advises consumers to speak to their physicians about their heart health."
Congress has also asked for records proving Jarvik took the medication, as he states in the ads.
"We're looking to see if there is wrongdoing but also we're looking to see if the law needs to be changed to give us a better level of protection for the consumers," Dingell said.